Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza.
Abbott TR, Dhamdhere G, Liu Y, Lin X, Goudy L, Zeng L, Chemparathy A, Chmura S, Heaton NS, Debs R, Pande T, Endy D, La Russa MF, Lewis DB, Qi LS
Cell. 2020 May 14;181(4):865-876.e12. doi: 10.1016/j.cell.2020.04.020. Epub 2020 Apr 29.
PubMed Article

Plasmids from Article

ID Plasmid Purpose
155303pSLQ5079_pHR_PGK_sfGFP_CoV-F1SARS-CoV-2 fluorescent reporter 1
155304pSLQ5080_pHR_PGK_sfGFP_CoV-F2SARS-CoV-2 fluorescent reporter 2
155305pSLQ5428_pHR_EF1a-mCherry-P2A-Rfx_Cas13d-2xNLS-3xFLAGLentiviral vector encoding Rfx Cas13d fused with 2xNLS, 3xFLAG, and 2A-tagged mCherry.
155306pSLQ5429_pUC_hU6-crScaffold_EF1a-BFPRfx Cas13d guide cloning pUC19 vector with constitutively expressed tagBFP
155307pSLQ5465_pHR_hU6-crScaffold_EF1a-PuroR-T2A-BFPRfx Cas13d guide cloning lentiviral vector with constitutively expressed puromycin resistance 2A-tagged with tagBFP

Antibodies from Article